These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7547005)

  • 1. Lingual haematoma after treatment with alteplase (recombinant tissue plasminogen activator) for acute myocardial infarction.
    McMechan SR; Morrow B; Campbell NP
    Br Heart J; 1995 Aug; 74(2):205. PubMed ID: 7547005
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lingual haematoma after thrombolysis for acute myocardial infarction].
    Jaffrelot M; Bourrigan P; Cracan A; Dewilde J; Mehu G
    Ann Fr Anesth Reanim; 2005 Mar; 24(3):306-7. PubMed ID: 15792570
    [No Abstract]   [Full Text] [Related]  

  • 3. Lingual haematoma after treatment with alteplase (recombinant tissue plasminogen activator) for acute myocardial infarction.
    Kounis NG; Zarras GM; Frangides C; Andreas A
    Heart; 1996 Apr; 75(4):427. PubMed ID: 8705778
    [No Abstract]   [Full Text] [Related]  

  • 4. Mental Dullness after thrombolytic therapy.
    Woo KS; Chan HC; Poon WS
    Postgrad Med J; 1997 Jun; 73(860):347-9. PubMed ID: 9246336
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombolytic therapy for myocardial infarction.
    Andreotti F
    N Engl J Med; 1998 Feb; 338(8):546; author reply 547. PubMed ID: 9471558
    [No Abstract]   [Full Text] [Related]  

  • 6. Atheroembolic disease following administration of tissue plasminogen activator (TPA).
    Aggarwal K; Tjahja IE
    Clin Cardiol; 1996 Nov; 19(11):906-8. PubMed ID: 8914787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experience with the thrombolytic therapy of myocardial infarct].
    Gospodarenko AL; Ardashev VN; Tiurin VP; Chernetsov VA; Iakovlev VB; Vrublevskiĭ OIu; Makarenko AS; Sokolianskiĭ NV; Chernov SA; Kucherov VV; Davrent'eva TA
    Voen Med Zh; 1997 Nov; 318(11):40-5. PubMed ID: 9461835
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
    Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
    JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Haematoma of the floor of the mouth associated to acute myocardial infarction].
    Pelaz A; Bayón J; Gallego L; Junquera L
    Acta Otorrinolaringol Esp; 2011; 62(6):462-4. PubMed ID: 21163462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraventricular bleeding after the use of thrombolytics in a cocaine user.
    LoVecchio F; Nelson L
    Am J Emerg Med; 1996 Nov; 14(7):663-4. PubMed ID: 8906766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal epidural hematoma associated with tissue plasminogen activator treatment of acute myocardial infarction.
    Baron EM; Burke JA; Akhtar N; Young WF
    Catheter Cardiovasc Interv; 1999 Dec; 48(4):390-6. PubMed ID: 10559822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bilateral intracranial hemorrhage following thrombolytic therapy with alteplase (rTPA) in acute myocardial infarction].
    Arbol Linde F; Marcos Sánchez F; Merlo González V; Simón Martín A; Quintana Díaz M; López Onega P
    An Med Interna; 2002 Nov; 19(11):605-6. PubMed ID: 12522906
    [No Abstract]   [Full Text] [Related]  

  • 13. Anaphylactoid reaction during an infusion of recombinant tissue-type plasminogen activator for acute myocardial infarction.
    Massel D; Gill JB; Cairns JA
    Can J Cardiol; 1991 Sep; 7(7):298-302. PubMed ID: 1933636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spinal epidural hematoma following coronary thrombolysis with tissue plasminogen activator. Report of two cases.
    Sawin PD; Traynelis VC; Follett KA
    J Neurosurg; 1995 Aug; 83(2):350-3. PubMed ID: 7616284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of thrombolytic therapy with urokinase or recombinant tissue plasminogen activator for peripheral arterial occlusion: a comprehensive compilation of published work.
    Ouriel K; Kandarpa K
    J Endovasc Ther; 2004 Aug; 11(4):436-46. PubMed ID: 15298504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular arrhythmias during treatment with alteplase (recombinant tissue plasminogen activator) in suspected acute myocardial infarction.
    Wilcox RG; Eastgate J; Harrison E; Skene AM
    Br Heart J; 1991 Jan; 65(1):4-8. PubMed ID: 1899582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of reteplase with alteplase for acute myocardial infarction.
    Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators
    N Engl J Med; 1997 Oct; 337(16):1118-23. PubMed ID: 9340503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haematoma of the hand as a complication of thrombolysis for myocardial infarction.
    Ahmed K; Yavari A; Walker DM; Buchanan JA
    J Hand Surg Eur Vol; 2007 Dec; 32(6):720-1. PubMed ID: 17993444
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of combined administration of saruplase and single-chain alteplase on coronary recanalization in acute myocardial infarction.
    Tranchesi B; Bellotti G; Chamone DF; Verstraete M
    Am J Cardiol; 1989 Jul; 64(3):229-32. PubMed ID: 2500842
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.